Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Genomic aberrations and survival in chronic lymphocytic leukemia.
- H. Döhner, S. Stilgenbauer, P. Lichter
- Medicine, BiologyThe New England journal of medicine
- 28 December 2000
TLDR
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions.
- V. Goede, K. Fischer, M. Hallek
- MedicineThe New England journal of medicine
- 19 March 2014
TLDR
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
- R. Furman, J. Sharman, S. O'brien
- MedicineThe New England journal of medicine
- 12 March 2014
TLDR
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.
- Michael L. Wang, S. Rule, K. Blum
- MedicineThe New England journal of medicine
- 7 August 2013
TLDR
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
- A. Kröber, T. Seiler, S. Stilgenbauer
- BiologyBlood
- 15 August 2002
TLDR
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.
TLDR
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
TLDR
TP53 mutation and survival in chronic lymphocytic leukemia.
- T. Zenz, B. Eichhorst, S. Stilgenbauer
- Medicine, BiologyJournal of clinical oncology : official journal…
- 10 October 2010
TLDR
Mutations driving CLL and their evolution in progression and relapse
- D. Landau, E. Tausch, Catherine J. Wu
- Biology, MedicineNature
- 18 August 2015
TLDR
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias.
- H. Döhner, K. Fischer, S. Stilgenbauer
- Biology, MedicineBlood
- 15 March 1995
TLDR
...
1
2
3
4
5
...